Advertisement

Incremental dialysis in ESRD: systematic review and meta-analysis

  • Carlo GarofaloEmail author
  • Silvio Borrelli
  • Toni De Stefano
  • Michele Provenzano
  • Michele Andreucci
  • Gianfranca Cabiddu
  • Vincenzo La Milia
  • Valerio Vizzardi
  • Massimo Sandrini
  • Giovanni Cancarini
  • Adamasco Cupisti
  • Vincenzo Bellizzi
  • Roberto Russo
  • Paolo Chiodini
  • Roberto Minutolo
  • Giuseppe Conte
  • Luca De Nicola
Original Article
  • 53 Downloads

Abstract

Background

Incremental dialysis may preserve residual renal function and improve survival in comparison with full-dose dialysis; however, available evidence is limited. We therefore compared all-cause mortality and residual kidney function (RKF) loss in incremental and full-dose dialysis and time to full-dose dialysis in incremental hemodialysis (IHD) and incremental peritoneal dialysis (IPD).

Methods

We performed a systematic review and meta-analysis of cohort studies of adults with ESRD starting IHD and IPD. We identified in PubMed and Web of Science database all cohort studies evaluating incremental dialysis evaluating three outcomes: all-cause mortality, RKF loss, time to full dialysis. IPD was defined as < 3 daily dwells in Continuous Ambulatory Peritoneal Dialysis and < 5 sessions per week in Automated Peritoneal Dialysis, while IHD was defined as < 3 HD sessions per week.

Results

22 studies (75,292 participants), 15 in HD and 7 in PD, were analyzed. Mean age at dialysis start was 62 and 57 years in IHD and IPD subjects, respectively. When compared to full dose, incremental dialysis (IHD or IPD) had an overall mortality risk of 1.14 [95% CI 0.85–1.52] with high heterogeneity among studies (I2 86%, P < 0.001), and lower mean RKF loss (− 0.58 ml/min/months, 95% CI 0.16–1.01, P = 0.007). Overall, time to full-dose dialysis was 12.1 months (95% CI 9.8–14.3) with no difference between IHD and IPD (P = 0.217).

Conclusions

Incremental dialysis allows longer preservation of RKF thus deferring full-dose dialysis, by about 1 year in HD and PD, with no increase in mortality risk. Large and adequate studies are needed to confirm these findings.

Keywords

Incremental hemodialysis Incremental peritoneal dialysis Meta-analysis Systematic review ESRD 

Notes

Author Contributions

Research idea and study design: CG, RM, LDN, GC, TDS, MP, SB, MA, GC, VLM, VV, MS, GC, VB, RR, AC. Data acquisition: CG, SB, AC, MS, TDS. Data analysis/interpretation: CG, RM, LDN, GC, MP, SB, MA, GC, VLM, VV, MS, GC, VB, RR, AC. Statistical analysis: CG, PC, SB, MP, TDS. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. CG takes responsibility that this study has been reported honestly, accurately, and transparently; that no important aspects of the study have been omitted and that any discrepancies from the study as planned have been explained.

Funding

This work was endorsed by the Italian Society of Nephrology (Gruppi di Progetto sul “Trattamento Conservativo della Insufficienza Renale Cronica” e “Dialisi Peritoneale”) without any financial support.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

40620_2018_577_MOESM1_ESM.docx (39 kb)
Supplementary material 1 (DOCX 38 KB)

References

  1. 1.
    Pacilio M, Minutolo R, Garofalo C, Liberti ME, Conte G, De Nicola L (2016) Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question. J Nephrol 29(2):153–161CrossRefGoogle Scholar
  2. 2.
    United States Renal Data System (2015) USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BethesdaGoogle Scholar
  3. 3.
    ERA-EDTA Registry: ERA-EDTA Registry Annual Report (2013) Academic Medical Center. Department of Medical Informatics, AmsterdamGoogle Scholar
  4. 4.
    Thomas B, Wulf S, Bikbov B et al (2015) Maintenance dialysis throughout the World in Years 1990 and 2010. J Am Soc Nephrol 26(11):2621–2633CrossRefGoogle Scholar
  5. 5.
    Vanholder R, Lameire N, Annemans L, Van Biesen W (2016) Cost of renal replacement: how to help as many as possible while keeping expenses reasonable? Nephrol Dial Transpl 31(8):1251–1261CrossRefGoogle Scholar
  6. 6.
    Eckardt K, Gillespie I, Kronenberg F et al (2015) High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int 88(5):1117–1125CrossRefGoogle Scholar
  7. 7.
    Zareba W (2015) Initiation of dialysis: trigger or cause of cardiovascular events? Kidney Int 88(5):942–944CrossRefGoogle Scholar
  8. 8.
    Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW (2006) Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 47(5):830–841CrossRefGoogle Scholar
  9. 9.
    McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3(1):19–26CrossRefGoogle Scholar
  10. 10.
    Burton JO, Jefferies HJ, Selby NM, McIntyre CW (2009) Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4(12):1925–1931CrossRefGoogle Scholar
  11. 11.
    McIntyre CW (2010) Haemodialysis-induced myocardial stunning in chronic kidney disease—a new aspect of cardiovascular disease. Blood Purif 292:105–110CrossRefGoogle Scholar
  12. 12.
    Quinn RR, Hux JE, Oliver MJ et al (2011) Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol 22(8):1534–1542CrossRefGoogle Scholar
  13. 13.
    Yeates K, Zhu N, Vonesh E et al (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transpl 27(9):3568–3575CrossRefGoogle Scholar
  14. 14.
    Mehrotra R, Chiu YW, Kalantar-Zadeh K et al (2011) Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171(2):110–118CrossRefGoogle Scholar
  15. 15.
    Kumar VA, Sidell MA, Jones JP, Vonesh EF (2014) Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int 86(5):1016–1022CrossRefGoogle Scholar
  16. 16.
    Basile C, Casino FG, Kalantar-Zadeh K (2017) Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol 30(4):521–529CrossRefGoogle Scholar
  17. 17.
    Kalantar-Zadeh K, Crowley ST, Beddhu S et al (2017) Renal replacement therapy and incremental hemodialysis for veterans with advanced chronic kidney disease. Semin Dial 30(3):251–261CrossRefGoogle Scholar
  18. 18.
    Teitelbaum I (2018) Crafting the prescription for patients starting peritoneal dialysis. Clin J Am Soc Nephrol 13(3):483–485CrossRefGoogle Scholar
  19. 19.
    Kalantar-Zadeh K, Kovesdy CP, Streja E et al (2017) Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transpl 32(suppl_2):ii91–ii98CrossRefGoogle Scholar
  20. 20.
    Wang M, Obi Y, Streja E et al (2018) Impact of residual kidney function on hemodialysis adequacy and patient survival. Nephrol Dial Transpl.  https://doi.org/10.1093/ndt/gfy060 Google Scholar
  21. 21.
    Green JPHS (2011) Cochrane handbook for systematic reviews of interventions. http://www.cochrane.org/training/cochrane-handbook. Accessed 9 Apr 2016
  22. 22.
    Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefGoogle Scholar
  23. 23.
    Wells G, Shea B, O’Connell D et al (2017) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non randomized studies in meta-analyses. Ottawa Health Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 13 May 2017
  24. 24.
    Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928.  https://doi.org/10.1136/bmj.d5928 CrossRefGoogle Scholar
  25. 25.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRefGoogle Scholar
  26. 26.
    Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8(47):15–17Google Scholar
  27. 27.
    Van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21(4):589–624CrossRefGoogle Scholar
  28. 28.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefGoogle Scholar
  29. 29.
    Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C (2012) Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 32(6):767–776Google Scholar
  30. 30.
    Mathew A, Obi Y, Rhee CM et al (2016) Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis. Kidney Int 90(5):1071–1079CrossRefGoogle Scholar
  31. 31.
    Merino JL, Domínguez P, Bueno B, Amézquita Y, Espejo B, Paraíso V (2017) Application of a pattern of incremental haemodialysis, based on residual renal function, when starting renal replacement therapy. Nefrologia 37(1):39–46CrossRefGoogle Scholar
  32. 32.
    Ghahremani-Ghajar M, Rojas-Bautista V, Lau WL et al (2017) Incremental hemodialysis: the University of California Irvine experience. Semin Dial 30(3):262–269CrossRefGoogle Scholar
  33. 33.
    Hanson JA, Hulbert-Shearon TE, Ojo AO et al (1999) Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19(6):625–633CrossRefGoogle Scholar
  34. 34.
    Stankuvienė A, Ziginskienė E, Kuzminskis V, Bumblytė IA (2010) Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005. Medicina (Kaunas) 46(8):516–521CrossRefGoogle Scholar
  35. 35.
    Lin X, Yan Y, Ni Z et al (2012) Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif 33(1–3):66–72CrossRefGoogle Scholar
  36. 36.
    Elamin S, Abu-Aisha H (2012) Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transpl 5(2):81–86Google Scholar
  37. 37.
    Caria S, Cupisti A, Sau G, Bolasco P (2014) The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol 15:172CrossRefGoogle Scholar
  38. 38.
    Hwang HS, Hong YA, Yoon HE et al (2016) Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function. Medicine (Baltimore) 95(7):e2767CrossRefGoogle Scholar
  39. 39.
    Park JI, Park JT, Kim YL et al (2017) Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea. Nephrol Dial Transpl 32(2):355–363Google Scholar
  40. 40.
    Obi Y, Streja E, Rhee CM et al (2016) incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68(2):256–265CrossRefGoogle Scholar
  41. 41.
    Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14(1):59–64CrossRefGoogle Scholar
  42. 42.
    Panaput T, Thinkhamrop B, Domrongkitchaiporn S et al (2014) Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif 38(3–4):253–262CrossRefGoogle Scholar
  43. 43.
    Mukherjee T, Devi G, Geetha S, Anchan NJ, Sankarasubbaiyan S (2017) A comparison of practice pattern and outcome of twice-weekly and thrice-weekly hemodialysis patients. Indian J Nephrol 27(3):185–189CrossRefGoogle Scholar
  44. 44.
    Williams PF (1999) Timely initiation of dialysis. Am J Kidney Dis 34(3):594–595CrossRefGoogle Scholar
  45. 45.
    De Vecchi AF, Scalamogna A, Finazzi S, Colucci P, Ponticelli C (2000) Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int 20(4):412–417Google Scholar
  46. 46.
    Neri L, Viglino G, Cappelletti A, Gandolfo C, Barbieri S (2003) Incremental dialysis with automated peritoneal dialysis. Adv Perit Dial 19:93–96Google Scholar
  47. 47.
    Viglino G, Neri L, Barbieri S (2008) Incremental peritoneal dialysis: effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int Suppl.  https://doi.org/10.1038/sj.ki.5002601 Google Scholar
  48. 48.
    Jeloka T, Sanwaria P, Chaudhari L, Periera A (2013) “Ico-Alone” single nocturnal exchange to initiate peritoneal dialysis in patients with residual renal function-Five year, single centre experience. Indian J Nephrol 23(4):276–279CrossRefGoogle Scholar
  49. 49.
    Sandrini M, Vizzardi V, Valerio F et al (2016) Incremental peritoneal dialysis: a 10 year single-centre experience. J Nephrol 29(6):871–879CrossRefGoogle Scholar
  50. 50.
    Domenici A, Comunian MC, Fazzari L et al (2011) Incremental peritoneal dialysis favourably compares with hemodialysis as a bridge to renal transplantation. Int J Nephrol 2011:204216.  https://doi.org/10.4061/2011/204216 CrossRefGoogle Scholar
  51. 51.
    Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64(2):181–186CrossRefGoogle Scholar
  52. 52.
    Morelli E, Baldi R, Barsotti G et al (1987) Combined therapy for selected chronic uremic patients: infrequent hemodialysis and nutritional management. Nephron 47(3):161–166CrossRefGoogle Scholar
  53. 53.
    Locatelli F, Andrulli S, Pontoriero G, Di Filippo S, Bigi MC (1994) Supplemented low-protein diet and once weekly hemodialysis. Am J Kidney Dis 24(2):192–204CrossRefGoogle Scholar
  54. 54.
    Penne EL, van der Weerd NC, Blankestijn PJ et al (2010) Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 5(1):80–86CrossRefGoogle Scholar
  55. 55.
    Fry AC, Singh DK, Chandna SM, Farrington K (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25(3):295–302CrossRefGoogle Scholar
  56. 56.
    Gerhardt T, Pöge U, Stoffel-Wagner B et al (2008) Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Nephrol Dial Transpl 23(1):309–314CrossRefGoogle Scholar
  57. 57.
    Krediet RT (2006) How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transpl 21(Suppl 2):ii42–ii46CrossRefGoogle Scholar
  58. 58.
    Yang PY, Lin JL, Lin-Tan DT et al (2009) Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Ren Fail 31(6):423–430CrossRefGoogle Scholar
  59. 59.
    Tian JP, Du FH, Cheng LT, Wang T (2009) Residual renal function and arterial stiffness mediated the blood pressure change during interdialytic weight gain in hemodialysis patients. Hemodial Int 13(4):479–486CrossRefGoogle Scholar
  60. 60.
    Borrelli S, Leonardis D, Minutolo R et al (2015) Epidemiology of CKD regression in patients under nephrology care. PLoS One.  https://doi.org/10.1371/journal.pone.0140138.e Google Scholar
  61. 61.
    Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transpl 30(10):1602–1604CrossRefGoogle Scholar
  62. 62.
    Roggeri A, Roggeri DP, Zocchetti C, Bersani M, Conte F (2017) ReNe (Renal Lombardy Network); additional contributors from ReNe Network. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis. J Nephrol 30(2):263–269CrossRefGoogle Scholar
  63. 63.
    Bolasco P, Cupisti A, Locatelli F, Caria S, Kalantar-Zadeh K (2016) Dietary management of incremental transition to dialysis therapy: once-weekly hemodialysis combined with low-protein diet. J Ren Nutr 26(6):352–359CrossRefGoogle Scholar
  64. 64.
    Mathew AT, Obi Y, Rhee CM, Chou JA, Kalantar-Zadeh K (2018) Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis? Semin Dial 31(4):343–352CrossRefGoogle Scholar

Copyright information

© Italian Society of Nephrology 2019

Authors and Affiliations

  • Carlo Garofalo
    • 1
    Email author
  • Silvio Borrelli
    • 1
  • Toni De Stefano
    • 1
  • Michele Provenzano
    • 2
  • Michele Andreucci
    • 2
  • Gianfranca Cabiddu
    • 3
  • Vincenzo La Milia
    • 4
  • Valerio Vizzardi
    • 5
  • Massimo Sandrini
    • 5
  • Giovanni Cancarini
    • 5
  • Adamasco Cupisti
    • 6
  • Vincenzo Bellizzi
    • 7
  • Roberto Russo
    • 8
  • Paolo Chiodini
    • 9
  • Roberto Minutolo
    • 1
  • Giuseppe Conte
    • 1
  • Luca De Nicola
    • 1
  1. 1.Division of Nephrology, Department of Scienze Mediche e Chirurgiche AvanzateUniversity of Campania “Luigi Vanvitelli”NaplesItaly
  2. 2.Nephrology and Dialysis DivisionUniversity Magna Graecia in CatanzaroCatanzaroItaly
  3. 3.Nephrology and Dialysis DivisionG. Brotzu HospitalCagliariItaly
  4. 4.Nephrology and Dialysis DivisionE. Bassini HospitalMilanItaly
  5. 5.Nephrology and Dialysis DivisionASST Spedali Civili and University of BresciaBresciaItaly
  6. 6.Department of Clinical and Experimental MedicineUniversity of PisaPisaItaly
  7. 7.Ruggi d’Aragona Hospital in SalernoBariItaly
  8. 8.Azienda Ospedaliera Universitaria PoliclinicoBariItaly
  9. 9.Statistic and Epidemiologic DivisionUniversity L. Vanvitelli in NaplesNaplesItaly

Personalised recommendations